Difference between revisions of "Dapsone (Aczone)"
Warner-admin (talk | contribs) m (Text replacement - "[[Category:Drugs FDA" to "[[Category:FDA") |
Warner-admin (talk | contribs) m (Text replacement - "please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [https://online.lexi.com/lco/action/login UpToDate Lexidrug], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information" to "please refer to your preferred pharmacopeias or the prescribing information") |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 4: | Line 4: | ||
<br>Extravasation: N/A | <br>Extravasation: N/A | ||
| − | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias | + | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias or the prescribing information. |
==Diseases for which it is used== | ==Diseases for which it is used== | ||
| − | ''No known antineoplastic properties. Used as an alternative to [[Trimethoprim | + | ''No known antineoplastic properties. Used as an alternative to [[Trimethoprim-Sulfamethoxazole (Bactrim DS)]] or [[Pentamidine (Nebupent)]] for PCP/PJP prophylaxis.'' |
==Also known as== | ==Also known as== | ||
Latest revision as of 01:02, 29 June 2024
General information
Class/mechanism: Antibacterial, inhibits bacterial synthesis of dihydrofolic acid, via competition with para-aminobenzoate for the active site of dihydropteroate synthetase.
Route: PO
Extravasation: N/A
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias or the prescribing information.
Diseases for which it is used
No known antineoplastic properties. Used as an alternative to Trimethoprim-Sulfamethoxazole (Bactrim DS) or Pentamidine (Nebupent) for PCP/PJP prophylaxis.
Also known as
- Brand name: Aczone